According to SEC filings for the period ending December 2025, Design Therapeutics, Inc. (NASDAQ:DSGN) is held by 111 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 31 Dec, 2025 | 6,526,476 | 0 | 0.00% | $61,218,345.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 5,372,004 | 2,031,452 | 60.81% | $50,389,398.00 |
| Logos Global Management LP | 31 Dec, 2025 | 2,500,000 | -1,155,000 | -31.60% | $23,450,000.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 2,233,099 | 520,217 | 30.37% | $20,946,469.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 2,117,156 | 72,768 | 3.56% | $19,858,924.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,630,910 | 187,209 | 12.97% | $15,297,936.00 |
| Vivo Capital, LLC | 31 Dec, 2025 | 1,612,903 | 1,612,903 | 0.00% | $15,129,030.00 |
| Almitas Capital LLC | 31 Dec, 2025 | 1,530,435 | -1,530,435 | -50.00% | $14,355,480.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 1,461,381 | 985,682 | 207.21% | $13,707,754.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,179,817 | 103,581 | 9.62% | $11,066,683.00 |
| Woodline Partners LP | 31 Dec, 2025 | 944,039 | 331,327 | 54.08% | $8,855,086.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 784,606 | -244,973 | -23.79% | $7,359,604.00 |
| FMR LLC | 31 Dec, 2025 | 771,268 | 30,419 | 4.11% | $7,234,494.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 702,306 | 526,315 | 299.06% | $6,587,630.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 679,590 | -16,023 | -2.30% | $6,375,975.00 |
| STATE STREET CORP | 31 Dec, 2025 | 647,636 | 13,239 | 2.09% | $6,074,826.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 612,768 | -4,721 | -0.76% | $5,742.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 521,000 | -1,432,547 | -73.33% | $4,886,980.00 |
| Caption Management, LLC | 31 Dec, 2025 | 500,000 | 500,000 | 0.00% | $4,690,000.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 459,874 | -94,146 | -16.99% | $4,313,618.00 |